0001567619-22-020800.txt : 20221123 0001567619-22-020800.hdr.sgml : 20221123 20221123093816 ACCESSION NUMBER: 0001567619-22-020800 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221121 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leonard Braden Michael CENTRAL INDEX KEY: 0001373603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39041 FILM NUMBER: 221412651 MAIL ADDRESS: STREET 1: 156 S. FIRST STREET CITY: ZIONSVILLE STATE: IN ZIP: 46077 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001692830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813039831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 BUSINESS PHONE: 415-505-0809 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 4 1 doc1.xml FORM 4 X0306 4 2022-11-21 0 0001692830 Satsuma Pharmaceuticals, Inc. STSA 0001373603 Leonard Braden Michael 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 0 0 1 0 Common Stock 2022-11-21 4 P 0 150000 0.7116 A 150000 D Common Stock 6440000 I Holding of BML Investment Partners, L.P. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.70 to $0.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Braden Michael Leonard 2022-11-23